pdf文档 D-半乳糖作用机制---Medchemexpress---MCE中国

专业资料 > IT&计算机 > 互联网 > 文档预览
3 页 1158 浏览 19 收藏 4.7分

摘要:•D-GalactoseInhibitorsProductData SheetAgonistsHY-N0210CASNo.:59-23-4分⼦式:C₆H₁₂O₆分⼦量:180.16作⽤靶点:EndogenousMetabolite作⽤通路:MetabolicEnzyme/Protease储存⽅式:Powder-20°C3years4°C2years-80°C6months-20°C1monthScreeningLibrariesInsolvent•Cat.No.:溶解性数据体外实验H2O:100mg/mL(555.06mM;Needultrasonic)DMSO:50mg/mL(277.53mM;Needultrasonic)SolventMass1mg5mg10mg1mM5.5506mL27.7531mL55.5062mL5mM1.1101mL5.5506mL11.1012mL10mM0.5551mL2.7753mL5.5506mLConcentration制备储备液请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。储备液的保存⽅式和期限:-80°C,6months;-20°C,1month。-80°C储存时,请在6个⽉内使⽤,-20°C储存时,请在1个⽉内使⽤。体内实验请根据您的实验动物和给药⽅式选择适当的溶解⽅案。以下溶解⽅案都请先按照InVitro⽅式配制澄清的储备液,再依次添加助溶剂:为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的⼯作液,建议您现⽤现配,当天

温馨提示:当前文档最多只能预览 5 页,若文档总页数超出了 5 页,请下载原文档以浏览全部内容。
D-半乳糖作用机制---Medchemexpress---MCE中国 第 1 页 D-半乳糖作用机制---Medchemexpress---MCE中国 第 2 页 D-半乳糖作用机制---Medchemexpress---MCE中国 第 3 页
本文档由 匿名用户2020-08-08 10:02:51上传分享
你可能在找
  • .:243984-11-4分⼦式:C₁₅H₁₇ClFNO₄S分⼦量:361.82作⽤靶点:Toll-likeReceptor(TLR);TNFReceptor;InterleukinRelated;Autophagy 作⽤通路:Immunology/Inflammation;Apoptosis;Autophagy储存⽅式:Powder-20°C3years4°C2years-80°C6months-20°C1monthScreeningLibrariesInsolvent SolventMass1mg5mg10mg1mM2.7638mL13.8190mL27.6381mL5mM0.5528mL2.7638mL5.5276mL10mM0.2764mL1.3819mL2.7638mLConcentration制备储备液请
    4.9 分 3 页 | 410.52 KB
  • .:1032900-25-6分⼦式:C₂₈H₃₆ClN₅O₃S分⼦量:558.14作⽤靶点:ALK;InsulinReceptor;IGF-1R作⽤通路:ProteinTyrosineKinase/RTK butsaturationunknown.SolventMass1mg5mg10mg1mM1.7917mL8.9583mL17.9167mL5mM0.3583mL1.7917mL3.5833mL10mM0.1792mL0.8958mL1.7917mLConcentration制备储备液请根据产品在不同溶剂中的溶解度选择合
    4.8 分 3 页 | 403.49 KB
  • .:85622-93-1分⼦式:C₆H₆N₆O₂分⼦量:194.15作⽤靶点:DNAAlkylator/Crosslinker;Autophagy;Apoptosis作⽤通路:CellCycle/DNADamage
    4.6 分 3 页 | 410.40 KB
  • .:63-39-8分⼦式:C₉H₁₅N₂O₁₅P₃分⼦量:484.14作⽤靶点:EndogenousMetabolite作⽤通路:MetabolicEnzyme/Protease储存⽅式:Powder• butsaturationunknown.SolventMass1mg5mg10mg1mM2.0655mL10.3276mL20.6552mL5mM0.4131mL2.0655mL4.1310mL10mM0.2066mL1.0328mL2.0655mLConcentration制备储备液请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液
    5.0 分 2 页 | 362.72 KB
  • .:4373-41-5分⼦式:C₃₀H₄₈O₄分⼦量:472.7作⽤靶点:NF-κB;Bacterial;HIV作⽤通路:NF-κB;Anti-infection储存⽅式:Powder-20°C3years4 SolventMass1mg5mg10mg1mM2.1155mL10.5775mL21.1551mL5mM0.4231mL2.1155mL4.2310mL10mM0.2116mL1.0578mL2.1155mLConcentration制备储备液请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液
    4.7 分 3 页 | 395.79 KB
  • .:79517-01-4分⼦式:C₅₁H₇₀N₁₀O₁₂S₂分⼦量:1079.29作⽤靶点:SomatostatinReceptor作⽤通路:GPCR/GProtein;NeuronalSignaling SolventMass1mg5mg10mg1mM0.9265mL4.6327mL9.2654mL5mM0.1853mL0.9265mL1.8531mL10mM0.0927mL0.4633mL0.9265mLConcentration制备储备液请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液
    4.6 分 3 页 | 404.21 KB
  • •GlycyrrhizicacidInhibitorsProductData Sheet1405-86-3分⼦式:C₄₂H₆₂O₁₆分⼦量:822.93作⽤靶点:VirusProtease作⽤通路:Anti-infection butsaturationunknown.SolventMass1mg5mg10mg1mM1.2152mL6.0759mL12.1517mL5mM0.2430mL1.2152mL2.4303mL10mM0.1215mL0.6076mL1.2152mLConcentration制备储备液请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液
    5.0 分 3 页 | 403.71 KB
  • .:1537032-82-8作⽤靶点:PD-1/PD-L1作⽤通路:Immunology/Inflammation储存⽅式:Pureform-20°C3years4°C2yearsInsolvent-80 :ScreeningLibrariesBIOLOGICALACTIVITY⽣物活性Avelumab是⼀个⼈IgG1抗PD-L1单克隆抗体,具有潜在的抗体依赖性细胞介导的细胞毒性作⽤。
    4.7 分 2 页 | 330.96 KB
  • .:173531-58-3分⼦式:C₂₄H₃₄ClN₃O₉P₂分⼦量:605.94作⽤靶点:Parasite作⽤通路:Anti-infection储存⽅式:Powder-20°C3years4°C2years SolventMass1mg5mg10mg1mM1.6503mL8.2516mL16.5033mL5mM0.3301mL1.6503mL3.3007mL10mM---------Concentration制备储备液请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液
    4.9 分 2 页 | 351.72 KB
  • .:1405-10-3分⼦式:C₂₃H₅₂N₆O₂₅S₃分⼦量:908.88作⽤靶点:Bacterial;CalciumChannel作⽤通路:Anti-infection;MembraneTransporter butsaturationunknown.SolventMass1mg5mg10mg1mM1.1003mL5.5013mL11.0026mL5mM0.2201mL1.1003mL2.2005mL10mM0.1100mL0.5501mL1.1003mLConcentration制备储备液请根据产品在不同溶剂中的溶解度选择合适的溶
    4.8 分 2 页 | 363.43 KB
本站APP下载(扫一扫)
活动:每周日APP免费下载全站文档
本站APP下载
热门文档